Publication | Closed Access

295 Capecitabine plus irinotecan (CAPIRI) vs capecitabine plus oxaliplatin (CAPOX) as first-line therapy of advanced colorectal cancer (ACRC): updated results of a randomized phase II trial

First-line TherapyOncologyGastrointestinal OncologyMedicineColorectal CancerPharmacotherapyCancer TreatmentAdvanced Colorectal CancerPharmacologyRadiation OncologyCancer ResearchUpdated ResultsMolecular Oncology